# OneBlood, Inc. – FDA Inspection, Jan 26, 2026

Source: https://www.keypedia.com/records/fda_inspections/oneblood-inc/6e05d5ea-152b-47b1-97fd-e6ebbdb88433
Source feed: FDA_Inspections

> FDA inspection 1304338 of OneBlood, Inc., January 26, 2026. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304338
- Company Name: OneBlood, Inc.
- Inspection Date: 2026-01-26
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Citation Count: 0

## Related Documents

- [FDA Inspection 1200346 - 2023-03-21](https://www.keypedia.com/records/fda_inspections/oneblood-inc/abd896a3-a5e7-41f0-9808-a26c20e95026)
- FDA Inspection 1080683 - 2019-02-21
- FDA Inspection 1012283 - 2017-02-02
- FDA Inspection 905875 - 2014-12-03
- FDA Inspection 817493 - 2013-01-30

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/annette-melendez/bc1a065d-6408-4c4b-9dcf-c6884e8a75c4)

Company: https://www.keypedia.com/companies/oneblood-inc/4ad69618-4cb7-4db0-be9a-d6ec5d8eafb9
